Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

349.53 -4.75 (-1.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 938,794
Open 351.76
Bid (Size) 348.00 (1)
Ask (Size) 358.06 (2)
Prev. Close 354.28
Today's Range 348.41 - 355.25
52wk Range 276.57 - 367.00
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Price Over Earnings Overview: Vertex Pharmaceuticals
Via Benzinga
2 Healthcare Stocks That Could Make You Richer
They've beaten the market before. 
Via The Motley Fool

Performance

YTD
+22.20%
+22.20%
1 Month
-0.31%
-0.31%
3 Month
+0.73%
+0.73%
6 Month
+11.18%
+11.18%
1 Year
+22.07%
+22.07%

More News

Read More
3 Unstoppable Stocks to Buy and Hold for the Next 20 Years
Via The Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
Via The Motley Fool
2 Top Trends to Invest $500 In Right Now
Via The Motley Fool
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years
Via The Motley Fool
Is NASDAQ:VRTX suited for quality investing?
Via Chartmill
Could These Be Vertex Pharmaceuticals' Most Promising Candidates?
Via The Motley Fool
Expert Ratings for Vertex Pharmaceuticals
Via Benzinga
Looking for Growth? These Companies' Revenue May Skyrocket
Via The Motley Fool
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
Via The Motley Fool
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
Via Benzinga
Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor for Children With Cystic Fibrosis Ages 2 Through 5
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Via Investor's Business Daily
Exposures Product Safety
3 Top Healthcare Stocks Defying the Bear Market
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Vertex Researchers Awarded 2024 Breakthrough Prize in Life Sciences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Better Bull Market Buy: CRISPR vs. Medtronic Stock
Via The Motley Fool
A Bull Market Is (Still) Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later
Via The Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
Via The Motley Fool
1 Top Pharma Growth Stock to Buy Today and Hold Forever
Via The Motley Fool
2 Top Biotech Stocks to Buy in September
Via The Motley Fool
September Rally? 3 Stocks to Buy Before Liftoff
Via InvestorPlace
3 Must-Know Tricks for Investing in Big Pharma Stocks
Via The Motley Fool
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.